Encompass Health Corporation (NYSE:EHC) Shares Sold by Trust Point Inc.

Trust Point Inc. lessened its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 50.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,154 shares of the company's stock after selling 2,171 shares during the quarter. Trust Point Inc.'s holdings in Encompass Health were worth $218,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in EHC. Colonial Trust Co SC bought a new position in shares of Encompass Health in the fourth quarter valued at about $29,000. Transce3nd LLC bought a new position in shares of Encompass Health in the fourth quarter valued at about $40,000. CBIZ Investment Advisory Services LLC raised its position in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the period. Signaturefd LLC raised its position in shares of Encompass Health by 21.6% in the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares during the period. Finally, C M Bidwell & Associates Ltd. raised its position in shares of Encompass Health by 73.6% in the fourth quarter. C M Bidwell & Associates Ltd. now owns 750 shares of the company's stock valued at $69,000 after purchasing an additional 318 shares during the period. Institutional investors own 97.25% of the company's stock.

Encompass Health Price Performance

EHC stock traded down $0.68 during mid-day trading on Friday, reaching $119.07. 1,297,450 shares of the company traded hands, compared to its average volume of 703,348. Encompass Health Corporation has a 52-week low of $82.74 and a 52-week high of $123.13. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06. The company has a fifty day moving average price of $115.81 and a 200-day moving average price of $103.99. The company has a market capitalization of $12.00 billion, a P/E ratio of 24.60, a P/E/G ratio of 2.42 and a beta of 0.89.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The business's revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the business earned $1.12 earnings per share. As a group, analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is 14.05%.

Insider Activity at Encompass Health

In related news, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the transaction, the chief executive officer now owns 527,070 shares of the company's stock, valued at $64,054,817.10. This trade represents a 18.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the firm's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock valued at $16,034,082 over the last 90 days. 2.00% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research report on Thursday, June 5th. Wall Street Zen downgraded shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. UBS Group increased their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. KeyCorp boosted their target price on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 27th. Finally, Truist Financial restated a "buy" rating and set a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Eight equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Encompass Health has an average rating of "Buy" and a consensus target price of $127.00.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.